Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Significant increases in serum 25(OH)D levels were observed in both groups over 24 months.

Source: 2.2. Serum Concentrations of 25(OH)D and Testosterone by Treatment Groups and Follow-Up Time. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Randomised controlled trial.

Randomised controlled trial

Assigns participants or groups to comparison interventions by chance.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

This study was conducted as part of the DEDiCa Trial, a multicenter randomized controlled trial involving hospitals across Italy [].

Source: Methods.

Eligible participants were women aged 30 to 74 years who had histologically confirmed primary breast cancer (stages I: III according to the TNM staging system), had undergone breast cancer surgery within the previous 12 months, had no evidence of metastatic disease, and had no contraindications for vitamin D supplementation or any components of the lifestyle treatment.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Vitamin D Supplementation and Testosterone Levels in Breast Cancer Survivors

Randomised controlled trial · International Journal of Molecular Sciences · 2025

Original publication title

Vitamin D Supplementation and Testosterone Levels in Breast Cancer Survivors

Anita Minopoli; Piergiacomo Di Gennaro; Giuseppe Porciello; Elvira Palumbo; Sara Vitale; Maria Grimaldi; Rosa Pica; Luca Falzone; Concetta Montagnese; Renato de Falco; Anna Crispo; Denise Giannascoli; Lucia Di Capua; Serena Meola; Monica Pinto; Michelino De Laurentiis; Vincenzo Di Lauro; Francesco Ferraù; Francesca Catalano; Francesco Messina; Massimiliano D’Aiuto; Massimo Rinaldo; Vincenzo Montesarchio; Davide Gatti; Agostino Steffan; Samuele Massarut; Jerry Polesel; Massimo Libra; Ernesta Cavalcanti; Egidio Celentano; Livia S. A. Augustin

© 2025 by the authors.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Vitamin D plays a key role in immune modulation, cell proliferation, and hormone regulation. Dysregulated testosterone may contribute to breast cancer progression. We investigated whether long-term vitamin D supplementation affects serum testosterone levels in breast cancer survivors. Complete data at baseline, 12, and 24 months were derived from 253 women with early-stage breast cancer participating in the DEDiCa trial and randomized to receive either a high-dose vitamin D to maintain serum 25(OH)D at 60 ng/mL (group A) or a standard dose to maintain serum levels at 30 ng/mL (group B).

Serum 25(OH)D levels significantly increased in both groups (p < 0.001). No significant changes in testosterone concentrations were observed between treatment groups over the 24 month treatment period (A: 0.125 to 0.140 ng/mL; B: 0.162 to 0.193 ng/mL; p = 0.682). Baseline serum testosterone levels emerged as the most significant predictor of testosterone trajectories, possibly modulated by hormone-suppressive therapy. These results are reassuring that vitamin D supplementation did not adversely affect testosterone levels in this population of breast cancer survivors and may partially concur with a healthy lifestyle to equilibrate testosterone levels.

Authors’ abstract

Vitamin D plays a key role in immune modulation, cell proliferation, and hormone regulation. Dysregulated testosterone may contribute to breast cancer progression. We investigated whether long-term vitamin D supplementation affects serum testosterone levels in breast cancer survivors. Complete data at baseline, 12, and 24 months were derived from 253 women with early-stage breast cancer participating in the DEDiCa trial and randomized to receive either a high-dose vitamin D to maintain serum 25(OH)D at 60 ng/mL (group A) or a standard dose to maintain serum levels at 30 ng/mL (group B).

Serum 25(OH)D levels significantly increased in both groups (p < 0.001). No significant changes in testosterone concentrations were observed between treatment groups over the 24 month treatment period (A: 0.125 to 0.140 ng/mL; B: 0.162 to 0.193 ng/mL; p = 0.682). Baseline serum testosterone levels emerged as the most significant predictor of testosterone trajectories, possibly modulated by hormone-suppressive therapy. These results are reassuring that vitamin D supplementation did not adversely affect testosterone levels in this population of breast cancer survivors and may partially concur with a healthy lifestyle to equilibrate testosterone levels.

Publication and source details

Original title: Vitamin D Supplementation and Testosterone Levels in Breast Cancer Survivors

Anita Minopoli; Piergiacomo Di Gennaro; Giuseppe Porciello; Elvira Palumbo; Sara Vitale; Maria Grimaldi; Rosa Pica; Luca Falzone; Concetta Montagnese; Renato de Falco; Anna Crispo; Denise Giannascoli; Lucia Di Capua; Serena Meola; Monica Pinto; Michelino De Laurentiis; Vincenzo Di Lauro; Francesco Ferraù; Francesca Catalano; Francesco Messina; Massimiliano D’Aiuto; Massimo Rinaldo; Vincenzo Montesarchio; Davide Gatti; Agostino Steffan; Samuele Massarut; Jerry Polesel; Massimo Libra; Ernesta Cavalcanti; Egidio Celentano; Livia S. A. Augustin

International Journal of Molecular Sciences · 2025

* Correspondence: l.augustin@istitutotumori.na.it© 2025 by the authors.2025https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).5XMILLE_2021_2Italian Ministry of Health Finalizzata grantRF-PE-2013-02358099Italian Ministry of Health “Ricerca Corrente”This work was supported by grant 5XMILLE_2021_2 and Italian Ministry of Health Finalizzata grant (RF-PE-2013-02358099) and partially supported by the Italian Ministry of Health “Ricerca Corrente”.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T00:58:35.784886+00:00

DOI: 10.3390/ijms262010030 · PMC12564732